Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 7651–7700 of 75441
each of the following directors of the Company (Irwin D. Simon, Anuraag Agarwal, Steven M. Cohen, Denise M. Faltischek, Michael F. Goss and Ira J. Lamel) resigned as a member of the board of directors of the Company as of the Effective Time.
On August 1, 2024, Hatem Abou-Sayed MD informed Elevai Labs Inc. (the “Company”) of his decision to resign as a member of the Board of Directors of the Company and as Chief Medical Officer effective as of August 1, 2024.
On August 1, 2024, Hatem Abou-Sayed MD informed Elevai Labs Inc. (the “Company”) of his decision to resign as a member of the Board of Directors of the Company and as Chief Medical Officer effective as of August 1, 2024.
On July 30, 2024, Edward Cong Wang, the Company’s interim Chief Financial Officer, resigned from that position.
On August 2, 2024, Nicholas A. Petruska resigned from all of his officer positions at the Company including as Executive Vice President, Chief Financial Officer and Secretary, as well as Principal Financial and Accounting Officer of the Company.
On August 2, 2024, Gregory D. Ethridge resigned from the Board of Directors (the "Board") of Hennessy Capital Investment Corp. VI (the “Company”), effective immediately.
On July 31, 2024, Hawkeye Systems, Inc. (the “Company”) was informed by Chris Mulgrew, the Company’s Chief Financial Officer and Director, that he will resign from such positions effective August 31, 2024.
On July 30, 2024, Rowena Ricalde notified The Vita Coco Company, Inc. (the “Company”), of her resignation as Chief Accounting Officer of the Company (“CAO”) and principal accounting officer of the Company (“PAO”), to be effective as of August 16, 2024, in order to pursue another opportunity.
Doran Hole who joined the Company on July 1, 2019 as Executive Vice President and Chief Financial Officer and on August 2, 2024 tendered his resignation effective August 30, 2024 to pursue other opportunities.
David Reichman, who has retired, subsequent to a previously approved succession plan, effective August 1, 2024, from his role as Chief Executive Officer.
On July 31, 2024, Marc Mazur, a Class III member of the Board of Directors of Celularity, notified the Board of Directors of his intention to resign as a member of the board and all committees thereof effective July 31, 2024.
On July 31, 2024, Frederic Pla notified the Company of his intent to retire from his position as Chief Operating Officer of the Company, effective August 16, 2024
will succeed Tony G. Bowen, the Company’s current Chief Financial Officer, whose retirement will be effective September 13, 2024.
On August 2, 2024, Christopher Weber, the Chief Revenue Officer of GitLab Inc. (the “Company”), gave notice to the Company of his resignation effective August 4, 2024.
JoAnne Foody will be transitioning from her role as the Company’s Chief Medical Officer and that her employment with the Company will end on or before September 16, 2024
On August 5, 2024, The Kraft Heinz Company (the “Company”) announced that Rashida La Lande, Executive Vice President and Chief Legal and Corporate Affairs Officer, will be stepping down from her role effective immediately.
On August 1, 2024, Anand Buch resigned as a director of Crexendo, Inc.
These appointments follow the resignation of Todd Crockett, which was received and became effective July 30, 2024.
On August 5, 2024, the Company announced that the Board and Peter Cameron Hyzer, the Company’s Chief Financial Officer (“CFO”), have agreed that Mr. Hyzer will depart from his position as CFO and principal financial officer (“PFO”), effective as of September 6, 2024.
On July 30, 2024, CACI International Inc (the “Company”) announced the departure of Todd Probert as the Company’s President, National Security and Innovative Solutions effective immediately.
A. Nigel Hearne will resign from his position as Executive Vice President, Oil, Products & Gas effective October 1, 2024, and retire from the Company on or about February 14, 2025.
Brian Karrip, Executive Vice President of First Commonwealth Financial Corporation (the “Company”) and Executive Vice President and Chief Credit Officer of First Commonwealth Bank, notified the Company that he intends to retire as of August 15, 2024.
On August 2, 2024, Ligand Pharmaceuticals Incorporated (the “Company”) announced that its President and Chief Operating Officer, Matthew Korenberg, will be departing from the Company.
David M. Urso, the Company’s President and Chief Executive Officer, and Richard G. Ghalie, M.D., its Chief Medical Officer, will be leaving the Company effective August 1, 2024.
David M. Urso, the Company’s President and Chief Executive Officer, and Richard G. Ghalie, M.D., its Chief Medical Officer, will be leaving the Company effective August 1, 2024.
On August 1, 2024, Novanta Inc. (the “Company”) announced that Brian Young, Chief Human Resources Officer (“CHRO”) of the Company, would no longer serve as the CHRO, effective on November 1, 2024, or such earlier date as may be agreed between Mr. Young and determined by the Company.
On July 30, 2024, Jennifer B. Morgan notified the Board of Directors (the “Board”) of Bumble Inc. (the “Company” or “Bumble”) of her decision to resign from the Board, effective as of July 30, 2024.
On July 31, 2024, Mr. Brian Protiva notified ADTRAN Holdings, Inc. (the “Company”) of his resignation from his role as a member of the Company’s Board of Directors (the “Board”), effective immediately.
On July 31, 2024 Mark A. Smith (“MAS”), commenced his long-anticipated retirement including from his various positions (including Director, President, Interim Chief Financial Officer and General Counsel) at the Company (and its subsidiaries) effective the end of business on July 31, 2024.
On July 29, 2024, Julie Weedman notified the Company that she would be retiring and resigning from her roles as Senior Vice President and Chief Financial Officer of the Company, effective on August 15, 2024.
Joanne M. Maguire notified the Company on July 29, 2024 of her decision to retire as a member of the Board, effective September 30, 2024
Vicki L. Avril-Groves will retire from the Board, effective August 31, 2024
Barbara R. Smith, the Executive Chairman of the Company’s Board of Directors (the “ Board ”), will retire from such position and from the Board, effective August 31, 2024
On July 29, 2024 (the “Transition Date”), Joel D. Anderson succeeded R. Michael Mohan, interim Chief Executive Officer of Petco Health and Wellness Company, Inc. (the “Company”), as the Chief Executive Officer of the Company.
Mr. Zerr expressed his interest in relinquishing his role on the board of managers (the “Board”) of the Sponsor as soon as practicable.
On August 1, 2024, Elizabeth A. Fetter, a member of the board of directors (the “Board”) of McGrath RentCorp (the “Company”) resigned from the Board, and all other positions she held as a member of any committee of the Board, effective immediately.
On July 29, 2024, Mr. John Zerr announced that he will be retiring from his positions with Invesco Ltd. and its affiliates, effective January 1, 2025.
On July 30, 2024, the sole member of the Sponsor appointed Ms. Melanie Ringold to replace Mr. John Zerr as a member of the Board, effective July 31, 2024.
Mr. Zerr expressed his interest in relinquishing his role on the board of managers (the “Board”) of the Sponsor as soon as practicable.
Mr. Zerr expressed his interest in relinquishing his role on the board of managers (the “Board”) of the Sponsor as soon as practicable.
On July 29, 2024, Mr. John Zerr announced that he will be retiring from his positions with Invesco Ltd. and its affiliates, effective January 1, 2025.
On July 29, 2024, Mr. John Zerr announced that he will be retiring from his positions with Invesco Ltd. and its affiliates, effective January 1, 2025.
On July 29, 2024, Mr. John Zerr announced that he will be retiring from his positions with Invesco Ltd. and its affiliates, effective January 1, 2025.
In connection with his pending retirement, Mr. Zerr expressed his interest in relinquishing his role on the board of managers (the “Board”) of the Managing Owner as soon as practicable.
In connection with his pending retirement, Mr. Zerr expressed his interest in relinquishing his role on the board of managers (the “Board”) of the Sponsor as soon as practicable.
On July 30, 2024, Invesco Group Services Inc., the sole member of the Managing Owner, appointed Ms. Melanie Ringold to replace Mr. John Zerr as a member of the Board, effective July 31, 2024.
On July 29, 2024, Mary Tagliaferri, M.D., informed the Board of Directors (the “Board”) of Enzo Biochem, Inc. (the “Company”) of her resignation as a member of the Board, effective August 6, 2024, to pursue other opportunities.
On July 29, 2024, Mr. Simeon Salzman, the Chief Financial Officer of Gryphon Digital Mining, Inc., a Delaware corporation (the “Company”), informed the Company of his decision to voluntarily resign from his position to pursue other professional opportunities (the “Resignation”).
On July 31, 2024, the Company also announced that John Aballi had been appointed as Interim Chief Financial Officer of the Company, replacing Kamal Adawi who no longer serves as Chief Financial Officer and Corporate Secretary of the Company, effective as of July 31, 2024.
replacing Kamal Adawi who no longer serves as Chief Financial Officer and Corporate Secretary of the Company, effective as of August 1, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.